Back to Search
Start Over
FDA Grants 'Breakthrough Therapy' Status To Potential Autism Drug
- Source :
- Palaestra. Spring 2018, Vol. 32 Issue 2, p58, 1 p.
- Publication Year :
- 2018
-
Abstract
- A major pharmaceutical company says it has received a designation from the Food and Drug Administration to help expedite what could be the first drug to treat the core symptoms [...]
Details
- Language :
- English
- ISSN :
- 87565811
- Volume :
- 32
- Issue :
- 2
- Database :
- Gale General OneFile
- Journal :
- Palaestra
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.559357079